Loading organizations...
Loading organizations...
Biopharmaceutical company developing multi-specific antibodies for treatmen
Allink Biotherapeutics has raised $89.0M across 2 funding rounds.
Allink Biotherapeutics has raised $89.0M in total across 2 funding rounds.
Allink Biotherapeutics has raised $89.0M in total across 2 funding rounds.
Allink Biotherapeutics's investors include 郭学婧, Tan Hong, 5Y Capital, Lapam Capital, Jiangtao Yu, Legend Capital, Vince Deng.
Allink Biotherapeutics has raised $89.0M across 2 funding rounds. Most recently, it raised $47.0M Series A Extension in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2025 | $47.0M Series A Extension | 郭学婧, Tan Hong | 5Y Capital, Lapam Capital |
| Nov 28, 2024 | $42.0M Series A | Jiangtao Yu, Legend Capital, Vince Deng |